BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37591209)

  • 1. Frontiers in Endoscopic Treatment for Gastroesophageal Reflux Disease.
    Ota K; Takeuchi T; Higuchi K; Sasaki S; Mori Y; Tanaka H; Hakoda A; Sugawara N; Iwatsubo T; Nishikawa H
    Digestion; 2024; 105(1):5-10. PubMed ID: 37591209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of endoscopic submucosal dissection for gastroesophageal reflux disease (ESD-G) for medication-refractory gastroesophageal reflux disease: 35 cases underwent ESD-G including 15 cases followed more than 5 years.
    Ota K; Takeuchi T; Kojima Y; Sugawara N; Nishida S; Iwatsubo T; Kawaguchi S; Harada S; Tokioka S; Higuchi K
    BMC Gastroenterol; 2021 Nov; 21(1):432. PubMed ID: 34794376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021.
    Iwakiri K; Fujiwara Y; Manabe N; Ihara E; Kuribayashi S; Akiyama J; Kondo T; Yamashita H; Ishimura N; Kitasako Y; Iijima K; Koike T; Omura N; Nomura T; Kawamura O; Ohara S; Ozawa S; Kinoshita Y; Mochida S; Enomoto N; Shimosegawa T; Koike K
    J Gastroenterol; 2022 Apr; 57(4):267-285. PubMed ID: 35226174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases.
    Sumi K; Inoue H; Kobayashi Y; Iwaya Y; Abad MRA; Fujiyoshi Y; Shimamura Y; Ikeda H; Onimaru M
    Dig Endosc; 2021 Mar; 33(3):347-354. PubMed ID: 32415898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease.
    Ota K; Takeuchi T; Harada S; Edogawa S; Kojima Y; Inoue T; Higuchi K
    Scand J Gastroenterol; 2014 Dec; 49(12):1409-13. PubMed ID: 25384555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short and long term effect of anti-reflux mucosectomy with cap-assisted endoscopic mucosal resection for refractory gastroesophageal disease.
    Lee YS; Kim JH; Yon DK; Yoo IK
    Surg Endosc; 2024 Apr; 38(4):2180-2187. PubMed ID: 38448622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic management of gastroesophageal reflux disease: Panacea for proton pump inhibitors dependent/refractory patients.
    Kalapala R; Singla N; Reddy DN
    Dig Endosc; 2022 May; 34(4):687-699. PubMed ID: 34651353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study on anti-reflux mucoplasty: Advancing endoscopic anti-reflux therapy for gastroesophageal reflux disease.
    Inoue H; Yamamoto K; Shimamura Y; Azuma D; Ushikubo K; Okada H; Kimoto Y; Nishikawa Y; Tanaka I; Tanabe M; Onimaru M; Navarro MJ
    Dig Endosc; 2024 Jun; 36(6):690-698. PubMed ID: 37899073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroesophageal Reflux Disease: Pathophysiology and New Treatment Trends.
    Kasugai K; Ogasawara N
    Intern Med; 2024 Jan; 63(1):1-10. PubMed ID: 36927966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study.
    Yoo IK; Ko WJ; Kim HS; Kim HK; Kim JH; Kim WH; Hong SP; Yeniova AÖ; Cho JY
    Surg Endosc; 2020 Mar; 34(3):1124-1131. PubMed ID: 31139995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Experience with Banded Anti-reflux Mucosectomy (ARMS) for GERD: Feasibility, Safety, and Technique (with Video).
    Hedberg HM; Kuchta K; Ujiki MB
    J Gastrointest Surg; 2019 Jun; 23(6):1274-1278. PubMed ID: 30734179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan.
    Shinozaki S; Osawa H; Kobayashi Y; Sakamoto H; Hayashi Y; Miura Y; Kawarai Lefor A; Yamamoto H
    Scand J Gastroenterol; 2018 Aug; 53(8):897-904. PubMed ID: 30056768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease.
    Niikura R; Yamada A; Hirata Y; Hayakawa Y; Takahashi A; Shinozaki T; Takeuchi Y; Fujishiro M; Koike K
    Intern Med; 2018 Sep; 57(17):2443-2450. PubMed ID: 29607951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacotherapeutic management of gastroesophageal reflux disease (GERD).
    Chapelle N; Ben Ghezala I; Barkun A; Bardou M
    Expert Opin Pharmacother; 2021 Feb; 22(2):219-227. PubMed ID: 32893683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Objective Outcomes of an Extended Anti-reflux Mucosectomy in the Treatment of PPI-Dependent Gastroesophageal Reflux Disease (with Video).
    He J; Yin Y; Tang W; Jiang J; Gu L; Yi J; Yan L; Chen S; Wu Y; Liu X
    J Gastrointest Surg; 2022 Aug; 26(8):1566-1574. PubMed ID: 35776296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New treatment method for refractory gastroesophageal reflux disease (GERD): C-BLART (clip band ligation anti-reflux therapy)-a short-term study.
    Liu S; Chai N; Zhai Y; Zou J; Feng X; Li Z; Li L; Zhang X; Wang X; Wang S; Linghu EQ
    Surg Endosc; 2020 Oct; 34(10):4516-4524. PubMed ID: 31728750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-reflux mucosectomy (ARMS) for refractory gastroesophageal reflux disease.
    Zhu X; Shen J
    Eur J Med Res; 2024 Mar; 29(1):185. PubMed ID: 38500203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and outcomes of anti-reflux mucosectomy for proton pump inhibitor dependent gastroesophageal reflux disease: First Indian study (with video).
    Patil G; Dalal A; Maydeo A
    Dig Endosc; 2020 Jul; 32(5):745-752. PubMed ID: 31834663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
    Okuyama M; Nakahara K; Iwakura N; Hasegawa T; Oyama M; Inoue A; Ishizu H; Satoh H; Fujiwara Y
    Digestion; 2017; 95(4):281-287. PubMed ID: 28501868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.
    Iwakiri K; Kinoshita Y; Habu Y; Oshima T; Manabe N; Fujiwara Y; Nagahara A; Kawamura O; Iwakiri R; Ozawa S; Ashida K; Ohara S; Kashiwagi H; Adachi K; Higuchi K; Miwa H; Fujimoto K; Kusano M; Hoshihara Y; Kawano T; Haruma K; Hongo M; Sugano K; Watanabe M; Shimosegawa T
    J Gastroenterol; 2016 Aug; 51(8):751-67. PubMed ID: 27325300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.